Chularat Hospital Toekomstige groei

Future criteriumcontroles 2/6

Chularat Hospital zal naar verwachting groeien in winst en omzet met respectievelijk 11.9% en 7.3% per jaar. De winst per aandeel zal naar verwachting groeien met 10.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16.3% zijn.

Belangrijke informatie

11.9%

Groei van de winst

10.6%

Groei van de winst per aandeel

Healthcare winstgroei	10.6%
Inkomstengroei	7.3%
Toekomstig rendement op eigen vermogen	16.3%
Dekking van analisten	Good
Laatst bijgewerkt	31 Oct 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

SET:CHG - Toekomstschattingen van analisten en financiële gegevens uit het verleden (THB Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	10,101	1,407	1,240	1,890	8
12/31/2025	9,381	1,300	1,169	1,730	10
12/31/2024	8,578	1,121	1,051	1,674	10
6/30/2024	8,520	1,056	932	1,841	N/A
3/31/2024	8,332	1,070	755	1,809	N/A
12/31/2023	8,014	1,046	952	2,087	N/A
9/30/2023	7,643	1,058	1,764	3,021	N/A
6/30/2023	7,574	990	1,880	2,951	N/A
3/31/2023	8,558	1,662	1,056	1,930	N/A
12/31/2022	10,408	2,778	1,806	2,629	N/A
9/30/2022	12,526	4,306	3,525	4,226	N/A
6/30/2022	14,883	5,611	3,167	3,779	N/A
3/31/2022	14,166	5,309	4,401	5,015	N/A
12/31/2021	11,999	4,204	3,522	4,005	N/A
9/30/2021	9,589	2,645	1,254	1,615	N/A
6/30/2021	6,598	1,363	1,423	1,721	N/A
3/31/2021	5,612	942	1,243	1,498	N/A
12/31/2020	5,462	877	1,004	1,298	N/A
9/30/2020	5,270	757	627	1,092	N/A
6/30/2020	5,241	744	518	1,122	N/A
3/31/2020	5,277	712	391	1,026	N/A
12/31/2019	5,188	705	241	974	N/A
9/30/2019	4,998	683	122	735	N/A
6/30/2019	4,715	565	119	715	N/A
3/31/2019	4,575	620	14	705	N/A
12/31/2018	4,427	634	45	695	N/A
9/30/2018	4,305	648	167	862	N/A
6/30/2018	4,187	665	247	952	N/A
3/31/2018	4,038	606	N/A	925	N/A
12/31/2017	3,894	565	N/A	910	N/A
9/30/2017	3,790	571	N/A	849	N/A
6/30/2017	3,721	563	N/A	805	N/A
3/31/2017	3,705	560	N/A	660	N/A
12/31/2016	3,655	564	N/A	705	N/A
9/30/2016	3,595	575	N/A	860	N/A
6/30/2016	3,436	536	N/A	704	N/A
3/31/2016	3,326	562	N/A	785	N/A
12/31/2015	3,171	538	N/A	698	N/A
9/30/2015	3,020	508	N/A	444	N/A
6/30/2015	2,904	514	N/A	555	N/A
3/31/2015	2,783	490	N/A	515	N/A
12/31/2014	2,695	481	N/A	446	N/A
9/30/2014	2,580	476	N/A	486	N/A
6/30/2014	2,497	475	N/A	368	N/A
3/31/2014	2,374	448	N/A	285	N/A
12/31/2013	2,234	414	N/A	309	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CHG ( 11.9% per jaar) ligt boven de spaarquote ( 2% ).

Winst versus markt: De winst van CHG ( 11.9% per jaar) zal naar verwachting langzamer groeien dan de markt TH ( 15.3% per jaar).

Hoge groeiwinsten: De winst van CHG zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van CHG ( 7.3% per jaar) zal naar verwachting sneller groeien dan de markt TH ( 6.4% per jaar).

Hoge groei-inkomsten: De omzet van CHG ( 7.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CHG zal naar verwachting over 3 jaar laag zijn ( 16.3 %).

Chularat Hospital Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Price target decreased by 7.2% to ฿3.85

Consensus EPS estimates increase by 18%

Consensus EPS estimates increase by 27%

Consensus forecasts updated

Recent updates

First half dividend of ฿0.02 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2024 to 30 June 2024, Payable on September 13, 2024

First quarter 2024 earnings released: EPS: ฿0.024 (vs ฿0.022 in 1Q 2023)

Now 22% overvalued

Now 21% overvalued

Now 21% overvalued

Final dividend of ฿0.05 announced

Full year 2023 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Third quarter 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chularat Hospital Public Company Limited Approves an Interim Dividend for the Six-Month Period Ended 30 June 2023, Payable on 8 September 2023

Price target decreased by 7.2% to ฿3.85

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ฿0.075 per share at 4.4% yield

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Upcoming dividend of ฿0.085 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2022 to 30 June 2022, Payable on September 9, 2022

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Consensus EPS estimates increase by 18%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ฿0.17 per share

Less than half of directors are independent

Consensus EPS estimates increase by 27%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Chularat Hospital Public Company Limited Proposes Interim Dividend, Payable on or Before May 20, 2022

Third quarter 2021 earnings released: EPS ฿0.14 (vs ฿0.026 in 3Q 2020)

Upcoming dividend of ฿0.03 per share

Consensus forecasts updated

Price target increased to ฿4.27

Chularat Hospital Public Company Limited (SET:CHG) acquired additional 10% stake in Ruampat Mae Sot International Company.

Consensus EPS estimates increase to ฿0.10

First quarter 2021 earnings released: EPS ฿0.023 (vs ฿0.017 in 1Q 2020)

Upcoming dividend of ฿0.03 per share

New 90-day high: ฿2.78

Full year 2020 earnings released: EPS ฿0.08 (vs ฿0.064 in FY 2019)

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 23, 2021

New 90-day high: ฿2.74

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ฿0.026

Upcoming Dividend of ฿0.02 Per Share

First half earnings released

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven